Literature DB >> 16604101

Clonal and non-clonal chromosome aberrations and genome variation and aberration.

Henry H Q Heng1, Guo Liu, Steven Bremer, Karen J Ye, Joshua Stevens, Christine J Ye.   

Abstract

The theoretical view that genome aberrations rather than gene mutations cause a majority of cancers has gained increasing support from recent experimental data. Genetic aberration at the chromosome level is a key aspect of genome aberration and the systematic definition of chromosomal aberrations with their impact on genome variation and cancer genome evolution is of great importance. However, traditionally, efforts have focused on recurrent clonal chromosome aberrations (CCAs). The significance of stochastic non-clonal chromosome aberrations (NCCAs) is discussed in this paper with emphasis on the simple types of NCCAs that have until recently been considered "non-significant background". Comparison of various subtypes of transitional and late-stage CCAs with simple and complex types of NCCAs has uncovered a dynamic relationship among NCCAs, CCAs, overall genomic instability, and karyotypic evolution, as well as the stochastic nature of cancer evolution. Here, we review concepts and methodologies to measure NCCAs and discuss the possible causative mechanism and consequences of NCCAs. This study raises challenging questions regarding the concept of cancer evolution driven by stochastic chromosomal aberration mediated genome irregularities that could have repercussions reaching far beyond cancer and organismal genomes.

Entities:  

Mesh:

Year:  2006        PMID: 16604101     DOI: 10.1139/g06-023

Source DB:  PubMed          Journal:  Genome        ISSN: 0831-2796            Impact factor:   2.166


  18 in total

1.  Single cell heterogeneity: why unstable genomes are incompatible with average profiles.

Authors:  Batoul Y Abdallah; Steven D Horne; Joshua B Stevens; Guo Liu; Andrew Y Ying; Barbara Vanderhyden; Stephen A Krawetz; Root Gorelick; Henry Hq Heng
Journal:  Cell Cycle       Date:  2013-10-01       Impact factor: 4.534

Review 2.  The Cellular Origin and Evolution of Breast Cancer.

Authors:  Mei Zhang; Adrian V Lee; Jeffrey M Rosen
Journal:  Cold Spring Harb Perspect Med       Date:  2017-03-01       Impact factor: 6.915

3.  Chromosomal heterogeneity and instability characterize pediatric medulloblastoma cell lines and affect neoplastic phenotype.

Authors:  Angel Mauricio Castro-Gamero; Kleiton Silva Borges; Regia Caroline Lira; Augusto Faria Andrade; Paola Fernanda Fedatto; Gustavo Alencastro Veiga Cruzeiro; Ricardo Bonfim Silva; Aparecida Maria Fontes; Elvis Terci Valera; Michael Bobola; Carlos Alberto Scrideli; Luiz Gonzaga Tone
Journal:  Cytotechnology       Date:  2013-01-17       Impact factor: 2.058

4.  Chromosome-wide gene dosage rebalance may benefit tumor progression.

Authors:  Honglei Zhang; Xing Yang; Xu Feng; Haibo Xu; Qin Yang; Li Zou; Mei Yan; Dequan Liu; Xiaosan Su; Baowei Jiao
Journal:  Mol Genet Genomics       Date:  2018-03-15       Impact factor: 3.291

5.  Sensitivity to cisplatin-induced mutations and elevated chromosomal aberrations in lymphocytes from sickle cell disease patients.

Authors:  Polyanna Miranda Alves; Paulo Roberto Juliano Martins; Francisca da Luz Dias; Rommel Mario Rodríguez Burbano; Maria de Lourdes Pires Bianchi; Lusânia Maria Greggi Antunes
Journal:  Clin Exp Med       Date:  2008-04-03       Impact factor: 3.984

6.  BubbleTree: an intuitive visualization to elucidate tumoral aneuploidy and clonality using next generation sequencing data.

Authors:  Wei Zhu; Michael Kuziora; Todd Creasy; Zhongwu Lai; Christopher Morehouse; Xiang Guo; Yinong Sebastian; Dong Shen; Jiaqi Huang; Jonathan R Dry; Feng Xue; Liyan Jiang; Yihong Yao; Brandon W Higgs
Journal:  Nucleic Acids Res       Date:  2015-11-17       Impact factor: 16.971

7.  Comparison of mitotic cell death by chromosome fragmentation to premature chromosome condensation.

Authors:  Joshua B Stevens; Batoul Y Abdallah; Sarah M Regan; Guo Liu; Steven W Bremer; Christine J Ye; Henry H Heng
Journal:  Mol Cytogenet       Date:  2010-10-19       Impact factor: 2.009

8.  DNA vaccination controls Her-2+ tumors that are refractory to targeted therapies.

Authors:  Paula J Whittington; Marie P Piechocki; Henry H Heng; Jennifer B Jacob; Richard F Jones; Jessica B Back; Wei-Zen Wei
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

9.  Genome based cell population heterogeneity promotes tumorigenicity: the evolutionary mechanism of cancer.

Authors:  Christine J Ye; Joshua B Stevens; Guo Liu; Steven W Bremer; Aruna S Jaiswal; Karen J Ye; Ming-Fong Lin; Lesley Lawrenson; Wayne D Lancaster; Markku Kurkinen; Joshua D Liao; C Gary Gairola; Malathy P V Shekhar; Satya Narayan; Fred R Miller; Henry H Q Heng
Journal:  J Cell Physiol       Date:  2009-05       Impact factor: 6.384

10.  Genome organization, instabilities, stem cells, and cancer.

Authors:  S Pazhanisamy; V Jyothi
Journal:  J Stem Cells Regen Med       Date:  2009-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.